Molecular profiling of pro-inflammatory HDL
促炎 HDL 的分子谱
基本信息
- 批准号:7789565
- 负责人:
- 金额:$ 38.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryApolipoprotein EApplications GrantsAtherosclerosisBiologicalBiological AssayBiological MarkersCardiovascular DiseasesClinicalCore ProteinCoronary ArteriosclerosisCoupledDevelopmentDietEarly DiagnosisEnzymesEpidemiologyEventGenerationsHaptoglobinsHemoglobinHemopexinHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHumanImmunoprecipitationInbred Strains MiceInflammatoryKnockout MiceKnowledgeLDL Cholesterol LipoproteinsLaboratoriesLinkMass Spectrum AnalysisModelingMolecular ProfilingMorbidity - disease rateMusNaturePeptide MappingPeptidesPhospholipase A2PlayPropertyProteinsReportingRiskRoleSamplingScreening for Ovarian CancerSerumSerum ProteinsSet proteinSocietiesTechnologyTherapeutic InterventionTimeTreatment EfficacyWestern Blottingbasemimeticsmortalitymouse modelnovelprotein profilingresearch studysurface enhanced laser desorption ionization
项目摘要
DESCRIPTION (provided by applicant): Atherosclerosis is the leading cause of morbidity and mortality in the Western society. High density lipoprotein (HDL) cholesterol and low density lipoprotein (LDL) cholesterol are good epidemiological predictors of risk for clinical events caused by coronary artery disease. Based on a number of recent studies in both animal models and human samples it is clear that the anti- or pro-inflammatory nature of HDL function and not HDL cholesterol levels is a sensitive indicator of the presence or absence of atherosclerosis. Hypothesis: We hypothesize that specific proteins associated with HDL are the functional determinants of its inflammatory properties and identification of such proteins will result in the development of i) novel biomarkers for the early detection of atherosclerosis, ii) biomarkers for following the efficacy of therapeutic approaches that are based on HDL function, and iii) new strategies for therapeutic interventions of atherosclerosis. Our laboratory utilizes ProteinChip technology coupled with surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to facilitate protein profiling. We have successfully utilized the technology and were the first to report the identification of three panels of biomarkers for the early detection of ovarian cancer. In preliminary serum protein profiling studies using SELDI-TOF-MS, we identified an eight-protein core signature (represented by their m/z peaks) that can be used as a serum biomarker panel for identifying pro-inflammatory HDL in mice. We further demonstrated that Hemoglobin-alpha, Hemoglobin-beta, and group XII PLA2 represent three of the peaks in the eight-protein core signature. In this grant proposal, we propose to i) identify and characterize the remaining five proteins that distinguish pro-inflammatory HDL from anti-inflammatory HDL, ii) determine the biological basis for the differences in Hemoglobin and group XII PLA2, between pro-inflammatory and anti-inflammatory HDL, and iii) determine the utility and function of the new biomarkers in apoA1 mimetic peptide based therapy in mouse models of atherosclerosis.
Atherosclerosis is an underlying cause for onset of cardiovascular diseases. The knowledge of protein profiles that distinguish pro-inflammatory HDL from anti-inflammatory HDL will provide will provide new strategies for early detection as well as therapeutic intervention of atherosclerosis.
描述(由申请人提供):动脉粥样硬化是西方社会发病率和死亡率的主要原因。高密度脂蛋白(HDL)胆固醇和低密度脂蛋白(LDL)胆固醇是由冠状动脉疾病引起的临床事件风险的良好流行病学预测指标。基于动物模型和人类样品的许多最新研究,很明显,HDL功能而不是HDL胆固醇水平的抗炎性质或促炎性质是对动脉粥样硬化的存在或不存在的敏感指标。假设:我们假设与HDL相关的特定蛋白质是其炎症特性的功能决定因素和这种蛋白质的鉴定将导致i)i)i)新型生物标志物,用于早期检测动脉粥样硬化,ii)生物标志物遵循基于HDL功能和III策略的策略的生物学方法,以遵循基于HDL Function和III的策略的效率。我们的实验室利用蛋白质芯片技术以及表面增强激光解吸/电离飞行时间质谱(SELDI-TOF-MS)来促进蛋白质分析。我们已经成功地利用了这项技术,并且是第一个报告鉴定三个生物标志物以早期检测到卵巢癌的人。在使用SELDI-TOF-MS的初步血清蛋白分析研究中,我们鉴定了一个八蛋白核心特征(由M/Z峰表示),该核心可以用作鉴定小鼠促炎HDL的血清生物标记面板。我们进一步证明了血红蛋白-Alpha,血红蛋白-beta和XII PLA2代表了八蛋白核心特征中的三个峰。在这项赠款的建议中,我们向i)提出建议,确定并表征其余的五种蛋白质,这些蛋白质将促炎性HDL与抗炎HDL区分开来,ii)确定血红蛋白和XII PLA2差异的生物学基础,在促炎和抗炎的HDL和III中,确定了尿液和III的生物群体,并确定了新的PETIS和III。动脉粥样硬化小鼠模型中的治疗。
动脉粥样硬化是导致心血管疾病发作的根本原因。将促炎性HDL与抗炎HDL区分开的蛋白质曲线的知识将为早期发现以及动脉粥样硬化的治疗干预提供新的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SRINIVASA T. Reddy其他文献
SRINIVASA T. Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SRINIVASA T. Reddy', 18)}}的其他基金
Novel Approaches for Improving Inflammation Resolution Following Chronic Exposure to Air Pollutants
改善长期接触空气污染物后炎症消退的新方法
- 批准号:
10348421 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
Novel Approaches for Improving Inflammation Resolution Following Chronic Exposure to Air Pollutants
改善长期接触空气污染物后炎症消退的新方法
- 批准号:
10581572 - 财政年份:2022
- 资助金额:
$ 38.63万 - 项目类别:
PON2 and PON3 proteins in Atherosclerosis
动脉粥样硬化中的 PON2 和 PON3 蛋白
- 批准号:
6560061 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
The role of PON2 and PON3 proteins in atherosclerosis
PON2和PON3蛋白在动脉粥样硬化中的作用
- 批准号:
8703745 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
The role of PON2 and PON3 proteins in atherosclerosis
PON2和PON3蛋白在动脉粥样硬化中的作用
- 批准号:
9066747 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
The role of PON2 and PON3 proteins in atherosclerosis
PON2和PON3蛋白在动脉粥样硬化中的作用
- 批准号:
8854124 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
The role of PON-2 and PON3 proteins in atherosclerosis
PON-2和PON3蛋白在动脉粥样硬化中的作用
- 批准号:
7643319 - 财政年份:2003
- 资助金额:
$ 38.63万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
- 批准号:
10680956 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 38.63万 - 项目类别: